Source:http://linkedlifedata.com/resource/pubmed/id/16789428
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-6-22
|
pubmed:abstractText |
Andrographolide 1, a diterpenoid lactone of the plant Andrographis paniculata, known to possess antitumour activity in in vitro and in vivo breast cancer models was subjected to semisynthesis leading to the preparation of a number of novel compounds. These compounds exhibited in vitro antitumour activity with moderate to excellent growth inhibition against MCF-7 (breast) and HCT-116 (colon) cancer cells. Compounds 3,19-(2-chlorobenzylidene)andrographolide(5), 3,19-(3-chlorobenzylidene)andrographolide(6), 3,19-(3-fluorobenzylidene) andrographolide(7), 3,19-(4-fluorobenzylidene)andrographolide(8), 3,19-(2-fluorobenzylidene)andrographolide(10), 3,19-(2-chloro-5-nitrobenzylidene)andrographolide (21), 3,19-(4-chlorobenzylidene)andrographolide(30) and 3,19-(2-chloro-4-fluorobenzylidene) andrographolide(31) were also screened against 60 NCI (National Cancer Institute, USA) human tumour cell lines derived from nine cancer cell types.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1475-6366
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
145-55
|
pubmed:dateRevised |
2007-3-21
|
pubmed:meshHeading |
pubmed-meshheading:16789428-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:16789428-Cell Line, Tumor,
pubmed-meshheading:16789428-Diterpenes,
pubmed-meshheading:16789428-Drug Screening Assays, Antitumor,
pubmed-meshheading:16789428-Humans,
pubmed-meshheading:16789428-Structure-Activity Relationship
|
pubmed:year |
2006
|
pubmed:articleTitle |
Semisynthesis and cytotoxic activities of andrographolide analogues.
|
pubmed:affiliation |
Clinical Pharmacology Laboratory, Division of Medical Sciences, National Cancer Centre, 11 Hospital Drive, 169610, Singapore.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|